Close Menu
NEW YORK (GenomeWeb News) - Following its initial public offering and Euronext listing on June 27, OncoMethylome Sciences said on Friday that it has raised an additional €3.3 million through the exercise of over-allotment option by Fortis and ING, the joint lead managers in the offering.
 
OncoMethylome granted the option on up to 440,000 new shares, at the IPO price of €7.5 per share.
 
As a result, the company's proceeds from the IPO total €25.3 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.